Literature DB >> 27249709

Basic Overview of Current Immunotherapy Approaches in Cancer.

Vamsidhar Velcheti1, Kurt Schalper1.   

Abstract

Recent success of immunotherapy strategies such as immune checkpoint blockade in several malignancies has established the role of immunotherapy in the treatment of cancer. Cancers use multiple mechanisms to co-opt the host-tumor immune interactions, leading to immune evasion. Our understanding of the host-tumor interactions has evolved over the past few years and led to various promising new therapeutic strategies. This article will focus on the basic principles of immunotherapy, novel pathways/agents, and combinatorial immunotherapies.

Entities:  

Mesh：

Year:  2016        PMID： 27249709     DOI： 10.1200/EDBK_156572

Source DB:  PubMed          Journal:  Am Soc Clin Oncol Educ Book        ISSN： 1548-8748


  37 in total

Review 1.  Advances in engineering local drug delivery systems for cancer immunotherapy.

Authors:  Peter Abdou; Zejun Wang; Qian Chen; Amanda Chan; Daojia R Zhou; Vivienne Gunadhi; Zhen Gu
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-04-07

Review 2.  Optimizing tumor immune response through combination of radiation and immunotherapy.

Authors:  Alissar El Chediak; Ali Shamseddine; Larry Bodgi; Jean-Pierre Obeid; Fady Geara; Youssef H Zeidan
Journal:  Med Oncol       Date:  2017-08-21       Impact factor: 3.064

3.  Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs.

Authors:  Mahendran Chinnappan; Akhil Srivastava; Narsireddy Amreddy; Mohammad Razaq; Vipul Pareek; Rebaz Ahmed; Meghna Mehta; Jo Elle Peterson; Anupama Munshi; Rajagopal Ramesh
Journal:  Cancer Lett       Date:  2020-05-19       Impact factor: 8.679

Review 4.  The evolution of interventional oncology in the 21st century.

Authors:  Thomas Helmberger
Journal:  Br J Radiol       Date:  2020-08-14       Impact factor: 3.039

5.  Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis.

Authors:  Vanda Téglási; Lilla Reiniger; Katalin Fábián; Orsolya Pipek; Irén Csala; Attila G Bagó; Péter Várallyai; Laura Vízkeleti; Lívia Rojkó; József Tímár; Balázs Döme; Zoltán Szállási; Charles Swanton; Judit Moldvay
Journal:  Neuro Oncol       Date:  2017-08-01       Impact factor: 12.300

Review 6.  Immunotherapy in AML: a brief review on emerging strategies.

Authors:  A Moeinafshar; S Hemmati; N Rezaei
Journal:  Clin Transl Oncol       Date:  2021-06-23       Impact factor: 3.405

7.  Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes.

Authors:  Charline Lafayolle de la Bruyère; Pierre-Jean Souquet; Stéphane Dalle; Pauline Corbaux; Amélie Boespflug; Michaël Duruisseaux; Lize Kiakouama-Maleka; Thibaut Reverdy; Madeleine Maugeais; Gulsum Sahin; Denis Maillet; Julien Péron
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

Review 8.  Immune Check-Point Inhibitors and Standard Chemoradiotherapy in Definitive Head and Neck Cancer Treatment.

Authors:  Francesca De Felice; Daniela Musio; Vincenzo Tombolini
Journal:  J Pers Med       Date:  2021-05-10

9.  Down-regulation of immune checkpoints by doxorubicin and carboplatin-containing neoadjuvant regimens in a murine breast cancer model.

Authors:  Sanambar Sadighi; Ramezanali Sharifian; Monireh Kazemimanesh; Ahad Muhammadnejad; Zahra Shahosseini; Saeid Amanpour; Samad Muhammadnejad
Journal:  Iran J Basic Med Sci       Date:  2021-04       Impact factor: 2.699

10.  Significance of N6-Methyladenosine RNA Methylation Regulators in Immune Infiltrates of Ovarian Cancer.

Authors:  Jing Gu; Fangfang Bi
Journal:  Front Genet       Date:  2021-07-07       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.